e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Desmosine, a biomarker for COPD: old and in the way
Luisetti M., Stolk J., Iadarola P.
Source:
Eur Respir J 2012; 39: 797-798
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luisetti M., Stolk J., Iadarola P.. Desmosine, a biomarker for COPD: old and in the way. Eur Respir J 2012; 39: 797-798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Towards the next stage of novel biomarker discussion in COPD: Tekizai-Tekisho
Source: Eur Respir J 2014; 43: 322-324
Year: 2013
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Pro-surfactant protein B, a promising BAL biomarker of COPD progression in heavy smokers, is increased by budesonide/formoterol short-term therapy
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Microalbuminuria as a cardiovascular biomarker in patients with COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker?
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Accelerated aging biomarkers in young, old, mild and severe COPD
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021
Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017
Year: 2018
The quest for biomarkers in asthma: challenging the T2
versus
non-T2 paradigm
Source: Eur Respir J, 59 (2) 2102669; 10.1183/13993003.02669-2021
Year: 2022
COPD in women: a particular phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
COPD in nonsmokers: the biomass hypothesis – to be or not to be?
Source: Eur Respir J 2014; 44: 8-10
Year: 2014
L-arginine pathway metabolites can predict exacerbation independently from beta blocker treatment in patients with COPD: A follow-up study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD
Source: Eur Respir J 2014; 43: 951-953
Year: 2014
Methylated arginine derivatives can differ stable and unstable patients with COPD
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Increased urinary LTE
4
in severe asthma and COPD: interim report from the BIOAIR study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
COPD specific comorbidities: A prospective, objective and controlled evaluation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
A follow-up study (MARKO) supports the need to change the diagnostic criteria for COPD
Source: International Congress 2016 – New approaches and finding in smoking cessation
Year: 2016
Spirometry screening in the community: is this an effective way of diagnosing early COPD?
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept